Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Intracerebral Hemorrhage
Interventions
DRUG

NXY-059

Trial Locations (64)

Unknown

Research Site, Birmingham

Research Site, Scottsdale

Research Site, Fort Smith

Research Site, Carmichael

Research Site, Sacramento

Research Site, San Diego

Research Site, San Jose

Research Site, Santa Rosa

Research Site, Walnut Creek

Research Site, Danbury

Research Site, Melbourne

Research Site, Ocala

Research Site, Pompano Beach

Research Site, Port Charlotte

Research Site, Punta Gorda

Research Site, Tampa

Research Site, Weston

Research Site, Atlanta

Research Site, Decatur

Research Site, Duluth

Research Site, Lawrenceville

Research Site, Honolulu

Research Site, Arlington Heights

Research Site, Maywood

Research Site, Fort Wayne

Research Site, Des Moines

Research Site, Louisville

Research Site, Marrero

Research Site, Shreveport

Research Site, South Weymouth

Research Site, Worcester

Research Site, Ann Arbor

Research Site, East Lansing

Research Site, Robbinsdale

Research Site, Kansas City

Research Site, Omaha

Research Site, Reno

Research Site, Edison

Research Site, Holmdel

Research Site, Morristown

Research Site, Ridgewood

Research Site, Summit

Research Site, Manhasset

Research Site, Schenectady

Research Site, Durham

Research Site, Winston-Salem

Research Site, Akron

Research Site, Cleveland

Research Site, Toledo

Research Site, Youngstown

Research Site, Oklahoma City

Research Site, Abington

Research Site, Danville

Research Site, Hershey

Research Site, Philadelphia

Research Site, Pittsburgh

Research Site, Bristol

Research Site, Memphis

Research Site, Houston

Research Site, Lubbock

Research Site, Virginia Beach

Research Site, Olympia

Research Site, Madison

Research Site, Marshfield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY